An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
Crossref DOI link: https://doi.org/10.1007/s12325-018-0827-5
Published Online: 2018-11-19
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pollock, Richard F. http://orcid.org/0000-0002-9873-7507
Muduma, Gorden
Funding for this research was provided by:
Pharmacosmos A/S
Text and Data Mining valid from 2018-11-19
Article History
Received: 4 September 2018
First Online: 19 November 2018